| 2844.20.00 | | Uranium enriched in U235 and its compounds; plutonium and its compounds; alloys, dispersions (including cermets), ceramic products and mixtures containing uranium enriched in U235, plutonium or compounds of these products | | Free | | Free |
| 2844.30 | | Uranium depleted in U235 and its compounds; thorium and its compounds; alloys, dispersions (including cermets), ceramic products and mixtures containing uranium depleted in U235, thorium, or compounds of these products: | | | | |
| 2844.50.00 | 00 | Spent (irradiated) fuel elements (cartridges) of nuclear reactors | kg | Free | | Free |
| 2848.00 | | Phosphides, whether or not chemically defined, excluding ferrophosphorus: | | | | |
| 2848.00.10 | 00 | Of copper (phosphor copper), containing more than 15 percent by weight of phosphorus | kg | 2.6% | Free (A,AU,BH, CA,CL,E,IL,J,JO, MA,MX,P,SG) | 32.5% |
| 2907.23.00 | 00 | 4,4'-Isopropylidenediphenol (Bisphenol A, Diphenylolpropane) and its salts | kg | 5.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2¡é/kg + 2.6% (SG) | 15.4¡é/kg + 44% |
| 2908.19.25 | 00 | Tetrabromobisphenol A | kg | 5.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX,P) 0.1¡é/kg + 3.1% (SG) | 15.4¡é/kg + 62% |
| 2912.29.30 | 00 | 3,4-Dimethylbenzaldehyde; Paraldehyde, USP grade; and p-Tolualdehyde | kg | Free | | 15.4¡é/kg + 58% |
| 2917.19.20 | 00 | Maleic acid; Succinnic acid derived in whole or in part from maleic anhydride or from cyclohexane; Glutaric acid derived in whole or in part from cyclopentanone; and anhydrides, halides, peroxides, peroxyacids and other derivatives of adipic acid, of fumaric acid derived in whole or in part from aromatic hydrocarbons, of maleic acid, of succinnic acid derived in whole or in part from maleic anhydride or from cyclohexane or of glutaric acid derived in whole or in part from cyclopentanone, not elsewhere specified or included: | | | | |
| 2918.22.10 | 00 | O-Acetylsalicylic acid (Aspirin) | kg | 6.5% | Free (A*,AU,BH, CA,CL,E,IL,J,JO, MA,MX, P,SG) | 15.4¡é/kg + 82% |
| 2919 | | Phosphoric esters and their salts, including lacto- phosphates; their halogenated, sulfonated, nitrated or nitrosated derivatives: | | | | |
| 2919.10.00 | 00 | Tris(2,3-dibromopropyl phosphate) | kg | 3.7% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
| 2919.90.15 | 00 | Triphenyl phosphate | kg | Free | | 15.4¡é/kg + 57% |
| 2920.11.00 | 00 | Thiophosphoric esters (phosphorodithioates) and their salts, their halogenated, sulfonated, nitrated or nitrosated derivatives: | | | | |
| 2920.19.10 | 00 | O,O-Dimethyl-O-(4-nitro-m-tolyl)phosphoro- thioate (Fenitrothion) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4¡é/kg + 41% |
| 2920.90.50 | 10 | Trimethyl phosphite, triethyl phosphite, dimethyl phosphite and diethyl phosphite | kg | | | |
| 2922.49.40 | 15 | l-Aspartic acid | kg | | | |
| 2923 | | Quaternary ammonium salts and hydroxides; lecithins and other phosphoaminolipids, whether or not chemically defined: | | | | |
| 2923.20 | | Lecithins and other phosphoaminolipids: | | | | |
| 2923.20.10 | 00 | Purified egg phospholipids, pharmaceutical grade meeting requirements of the U.S. Food and Drug Administration, for use in intravenous fat emulsion | kg | Free | | 16.5¡é/kg + 30% |
| 2924.12.00 | 00 | Fluoroacetamide (ISO), monocrotophos (ISO) and phosphamidon (ISO) | kg | 3.7% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
| 2924.29.10 | 00 | Acetanilide; N-Acetylsulfanilyl chloride; Aspartame; and 2-Methoxy-5-acetamino-N,N- bis(2-acetoxyethyl)aniline | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX,P) 0.2¡é/kg + 3.3% (SG) | 15.4¡é/kg + 58% |
| 2929.90.50 | 10 | N,N-Dialkyl (methyl, ethyl, n-propyl or isopropyl)phosphoramidic dihalides | kg | | | |
| 2929.90.50 | 20 | Dialkyl (methyl, ethyl, n-propyl or isopropyl)-N,N-dialkyl (methyl, ethyl, n-propyl or isopropyl)phosphoramidates | kg | | | |
| 2930.90.42 | 00 | O,O-Dimethyl-S-methylcarbamoyl- methyl phosphorodithioate; and Malathion | kg | Free | | 30.5% |
